Anti-PIGW monoclonal antibody

Pre-made anti-PIGW monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PIGW/PIGW products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2654-Ab-1/ GM-Tg-hg-IP2654-Ab-2Anti-Human PIGW monoclonal antibodyHuman
GM-Tg-rg-IP2654-Ab-1/ GM-Tg-rg-IP2654-Ab-2Anti-Rat PIGW monoclonal antibodyRat
GM-Tg-mg-IP2654-Ab-1/ GM-Tg-mg-IP2654-Ab-2Anti-Mouse PIGW monoclonal antibodyMouse
GM-Tg-cynog-IP2654-Ab-1/ GM-Tg-cynog-IP2654-Ab-2Anti-Cynomolgus/ Rhesus macaque PIGW monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2654-Ab-1/ GM-Tg-felg-IP2654-Ab-2Anti-Feline PIGW monoclonal antibodyFeline
GM-Tg-cang-IP2654-Ab-1/ GM-Tg-cang-IP2654-Ab-2Anti-Canine PIGW monoclonal antibodyCanine
GM-Tg-bovg-IP2654-Ab-1/ GM-Tg-bovg-IP2654-Ab-2Anti-Bovine PIGW monoclonal antibodyBovine
GM-Tg-equg-IP2654-Ab-1/ GM-Tg-equg-IP2654-Ab-2Anti-Equine PIGW monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2654-Ab-1/ GM-Tg-hg-IP2654-Ab-2; GM-Tg-rg-IP2654-Ab-1/ GM-Tg-rg-IP2654-Ab-2;
GM-Tg-mg-IP2654-Ab-1/ GM-Tg-mg-IP2654-Ab-2; GM-Tg-cynog-IP2654-Ab-1/ GM-Tg-cynog-IP2654-Ab-2;
GM-Tg-felg-IP2654-Ab-1/ GM-Tg-felg-IP2654-Ab-2; GM-Tg-cang-IP2654-Ab-1/ GM-Tg-cang-IP2654-Ab-2;
GM-Tg-bovg-IP2654-Ab-1/ GM-Tg-bovg-IP2654-Ab-2; GM-Tg-equg-IP2654-Ab-1/ GM-Tg-equg-IP2654-Ab-2
Products NameAnti-PIGW monoclonal antibody
Formatmab
Target NamePIGW
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PIGW monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2654-Ag-1Recombinant multi-species PIGW/ Gwt1/ HPMRS5 protein


    Target information

    Target IDGM-IP2654
    Target NamePIGW
    Gene ID284098,70325,378774,717088,100856602,101084242,768052,106780841
    Gene Symbol and Synonyms2610044A17Rik,Gwt1,HPMRS5,PIG-W,PIGW
    Uniprot AccessionQ7Z7B1,Q7TSN4,Q1LZA4
    Uniprot Entry NamePIGW_HUMAN,PIGW_RAT,PIGW_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000277161
    Target ClassificationN/A

    The target: PIGW, gene name: PIGW, also named as Gwt1, HPMRS5. The protein encoded by this gene is an inositol acyltransferase that acylates the inositol ring of phosphatidylinositol. This occurs in the endoplasmic reticulum and is a step in the biosynthesis of glycosylphosphatidylinositol (GPI), which anchors many cell surface proteins to the membrane. Defects in this gene are a cause of the age-dependent epileptic encephalopathy West syndrome as well as a syndrome exhibiting hyperphosphatasia and cognitive disability (HPMRS5). [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.